NYER MEDICAL GROUP INC
NT 10-K, 1997-03-26
MEDICAL, DENTAL & HOSPITAL EQUIPMENT & SUPPLIES
Previous: JPE INC, 10-K, 1997-03-26
Next: SCFC BOAT LOAN TRUST 1992-1, 10-K, 1997-03-26






                          United States
               Securities And Exchange Commission
                        Washington, D.C. 20549

                            FORM 12b-25          sec file number 000-20175
                   NOTIFICATION OF LATE FILING
(Check One):  XX Form 10-K  Form 20-F  Form 11-K  Form 10-Q  Form N-SAR

        For Period Ended 12/31/96
        ( ) Transition Report on Form 10-K
        ( ) Transition Report on Form 20-F
        ( ) Transition Report on Form 11-K
        ( ) Transition Report on Form 10-Q
        ( ) Transition Report on Form N-SAR
        For the Transition Period Ended:

Read Instruction (on back page) Before Preparing Form. Please Print or Type.

Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify
the item(s) to which the notification relates:

PART I-REGISTRANT INFORMATION

Full Name of Registrant
NYER MEDICAL GROUP, INC.

Former Name if Applicable
N/A

Address of Principal Executive Office (street and number)
1292 Hammond Street

City, State and Zip Code
Bangor, Maine 04401

PART II-RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed.  (Check box if appropriate)

X (a) The reasons described in reasonable detail in Part III of this
      form could not be eliminated without unreasonable effort or expense;

  (b) The subject annual report, semi-annual report, transition report
      on form 10-K, Form 20-F, 11-K, Form N-SAR, or portion thereof,
      will be filed on or before the fifteenth calendar day following
      the prescribed due date; or the subject quarterly report of
      transition report on Form 10-Q, or portion thereof will be filed 
      on or before the fifth calendar day following the prescribed due date;
      and

  (c) The accountant's statement or other exhibit required by Rule 12b-25(c)
      has been attached if applicable.
  
PART III-NARRATIVE

State below in reasonable detail the reasons why the Form 10-K, 11-K, 10-Q, 
N-SAR, or the transition report or portion thereof, could not be filed within
the prescribed time period. (Attach Extra Sheets if Needed)                    
                                                            
     Additional time is required in order to file an accurate and complete
Form 10-KSB due to an acquisition of a subsidiary and a recent partial spin-off
of another of its subsidiaries.
  
PART IV-OTHER INFORMATION

(1) Name and telephone number of person to contact in regard to this
    notification

    Karen L. Wright               (207)  942-5273

(2) Have all other periodic reports required under Section 13 or 15(d)
    of the Securities Exchange Act of 1934 or Section 30 of the in-
    vestment Company Act of 1940 during the preceding 12 months (or for
    such shorter) period that the registrant was required to file such
    reports) been filed?  If answer is no, identify report(s)       
                                  X YES   NO

(3) Is it anticipated that any significant change in results of operation
    from the corresponding period for the last fiscal year will be reflected
    by the earnings statements to be included in the subject report or
    portion thereof?                YES   X NO

    If so, attach an explanation of the anticipated change, both narratively
    and quantitatively, and, if appropriate, state the reasons why a
    reasonable estimate of the results cannot be made.


          Nyer Medical Group, Inc.
          (Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.

Date  March 26, 1997     /s/ Karen L. Wright, Treasurer
                         By  Karen L. Wright, Treasurer 

INSTRUCTION: The form may be signed by an executive officer of the
registrant or by any other duly authorized representative.  The name and
title of the person signing the form shall be typed or printed beneath the
signature.  If the statement is signed on behalf of the registrant by an
authorized representative (other than an executive officer), evidence of
the representative's authority to sign on behalf of the registrant shall be 
filed with the form.

                                                          
                                                                               
                                                   
                  


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission